Market Reports

Optimising labelling with robotics for improved accuracy and efficiency

Optimising labelling with robotics for improved accuracy and efficiency

Robotics can significantly enhance the labelling process during pharmaceutical packaging by increasing accuracy whilst reducing costs and labour
How efficient compressed air delivery can save you money

How efficient compressed air delivery can save you money

Investing in optimal filtration systems for compressed air delivery is crucial in saving money and reducing energy usage
How to proactively address EU HTAR implementation challenges before 2025

How to proactively address EU HTAR implementation challenges before 2025

Data landscape challenges within the European Union (EU) have historically been driven by the different laws, processes and regulatory standards of its 27 member states (MS). As a result, drug therapeutics and health technology developers have faced the challenge of duplication of assessment efforts
Adding more to the cell and gene therapy playbook

Adding more to the cell and gene therapy playbook

With notable advances in various forms of administration, including making the use of viral vectors safer, non-viral delivery with lipid nanoparticles and the growing application of electroporation, Dr Kevin Robinson (KSR) recently caught up with Jason Potter (JP), Director of Cell Biology R&D at Thermo Fisher Scientific, to learn more about how the company is helping the pharmaceutical industry to develop cell and gene therapies
What to consider for successful GMP Annex 1 implementation

What to consider for successful GMP Annex 1 implementation

In advance of her presentation at Manufacturing Chemist Live, Dr Nicole Hunter (NH), Head of Global Regulatory and Validation Services at Watson-Marlow Fluid Technology Solutions, and colleague Claire Hutchison (CH), Life Science Specialist, provide their insights on the updates to the European Commission’s Good Manufacturing Practices (GMP) Annex 1 and the role of single-use systems
Highly potent formulation development in oncology

Highly potent formulation development in oncology

Formulation development is a dynamic and experimental process. However, certain challenges are presented to CDMOs that add a layer of unnecessary pressure to the development process — some of which are avoidable. Louise Carpenter from PCI Pharma Services discusses
Going beyond the guidance: getting business benefit from change management

Going beyond the guidance: getting business benefit from change management

Change management offers a broad, system-wide perspective that includes the oversight and management of all changes and the change process. Michelle Anastasi of PharmaLex explores what good change management looks like and who should be involved
QMM: a natural development of pharmaceutical regulation?

QMM: a natural development of pharmaceutical regulation?

During the pandemic, we saw a rapid evolution of inspection approaches that showed how the sector — and indeed the regulators — can adapt to new operational models
SCHOTT Pharma reveals strong financial performance in fiscal year 2022

SCHOTT Pharma reveals strong financial performance in fiscal year 2022

In a record year of growth, sales increased by 27% to EUR 821 million and EBITDA by 33% to EUR 219 million on a preliminary basis
Made in Switzerland: blockchain enabled healthcare

Made in Switzerland: blockchain enabled healthcare

Interoperable blockchain-enabled solutions could eliminate waste, enhance security and privacy, build trust and, ultimately, benefit patients and the entire pharmaceutical value chain, say the founders of PharmaLedger. Dr Kevin Robinson dialled in to find out more
Brenntag signs multi-year partnership with Workday Human Capital

Brenntag signs multi-year partnership with Workday Human Capital

The chosen Workday HCM solution will be tailored and implemented in the course of 2023 to meet the needs of Brenntag
From food to pharma: antioxidant scavengers as a viable strategy to mitigate nitrosamines in drugs

From food to pharma: antioxidant scavengers as a viable strategy to mitigate nitrosamines in drugs

Stakeholders throughout the pharmaceutical value chain have had to deal with the recall of nitrosamine-containing medications, loss of revenue and, in some cases, reputational damage. Meanwhile, regulatory authorities have put stringent measures in motion to protect patients from potentially harmful medications, putting reformulation at the forefront of drug manufacturers’ minds, reports Anne-Cecile Bayne, Global Science and Innovation Lead, Pharma and Medical Nutrition at DSM
FUJIFILM launches viral vector feed designed to increase yields

FUJIFILM launches viral vector feed designed to increase yields

FUJIFILM Irvine Scientific has launched its BalanCD HEK293 Viral Feed designed to boost adeno-associated viral vector (AAV) production for gene therapy applications and viral vector-based vaccines
Catalent signs development deal with Ethicann for new fast-dissolve cannabinoid treatment

Catalent signs development deal with Ethicann for new fast-dissolve cannabinoid treatment

Catalent and Canadian/US cannabinoid drug therapy company Ethicann Pharmaceuticals have executed a development and license agreement that will use Catalent’s proprietary Zydis orally disintegrating tablet (ODT) technology
Host cell protein analysis: strategies to improve sensitivity and reproducibility

Host cell protein analysis: strategies to improve sensitivity and reproducibility

Given that the US FDA approved 25 new cellular and gene therapy products in 2022, gene-based vaccines and therapeutics have now entered the mainstream pharmaceutical industry. However, the rising interest in gene-based strategies puts pressure on manufacturers to demonstrate optimum efficacy and safety
Manufacturing Chemist LIVE 2023: Expert Speakers Wanted

Manufacturing Chemist LIVE 2023: Expert Speakers Wanted

Previous years have included presentations from the likes of NASA, AstraZeneca, GSK, CMAC and we are now looking for 2023's experts

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    From stockpiles to smart supply chains: how industry wants to fix Europe’s drug shortages An EU-level stockpile may work, but only if it’s flexible, closely monitored and built with logistics in mind. Industry players say drug security will depend less on volume and more on data, digital oversight and early collaboration throughout the supply chain
  2. A grandmaster’s approach to successful tableting Tableting is a fundamental unit operation in the production of pharmaceutical oral solid dosage forms. Despite its long history of use and the development of innovations such as extended dwell times, unique technologies that independently and simultaneously measure and control both tablet weight and hardness, and a weight control system that provides increased sensitivity at lower forces, production problems still occur. Here, Dr Harald Stahl, Group Director, Application and Strategy Management, GEA, provides some troubleshooting tips from an unlikely source: the chess board
  3. The modularisation of chemical API synthesis The modularisation of chemical synthesis pathways in pharmaceutical production can improve overall plant efficiency and reduce planning time. Glatt Ingenieurtechnik has optimised the active pharmaceutical ingredient (API) synthesis process and developed bespoke plant designs for several international customers
  4. Leaders of transformation Haig Armaghanian, founder and CEO of Haig Barrett, explores how synthetic biology pioneers are revolutionising therapeutic development
  5. Is the production of biologic drugs ready for an overhaul? Is the industry ready for a new manufacturing model? Mark Emalfarb, President and CEO of Dyadic International, thinks so and explains why to Dr Kevin Robinson

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy See all